Stock DANCAN DANCANN PHARMA A/S
Add to a list
To use this feature you must be a member
Log inSign up

Company Dancann Pharma A/S

Equities

DANCAN

DK0061410487

Biotechnology & Medical Research

End-of-day quote NORDIC GROWTH MARKET
Other stock markets
 15/01/2025 		5-day change 1st Jan Change
0.002000 DKK -9.09% Intraday chart for Dancann Pharma A/S -9.09% 0.00%
01-07 Dancann Pharma proposes a 1:1,000 reverse split FW
01-06 DanCann Pharma to Propose Share Consolidation to Reduce Costs MT

Business description: Dancann Pharma A/S

Dancann Pharma A/S is a Denmark-based pharmaceutical biotechnology company powered by cannabinoids. The Company is focused on discovering, developing, manufacturing, and commercializing of novel cannabinoid therapeutics in a broad range of disease areas. DanCann Pharma manufactures and distributes prescription drugs (Rx drugs) and over-the-counter drugs (OTCs), mainly focused on pain patients with alternative needs.

Number of employees: 12

Sales by Activity: Dancann Pharma A/S

Fiscal Period: December20192020202120222023

Pharmaceuticals

-422K -4.83M 874K 7.19M 7.15M
See all business segments

Geographical breakdown of sales: Dancann Pharma A/S

Fiscal Period: December20192020202120222023

Denmark

-422K -4.83M 874K 7.19M 7.15M
See all geographic segments

Managers: Dancann Pharma A/S

Director TitleAgeSince
Jeppe Rasmussen CEO
 Chief Executive Officer 30 19/03/2018
Peter Søndergaard DFI
 Director of Finance/CFO 53 03/01/2023
See DANCANN PHARMA A/S governance

Members of the board: Dancann Pharma A/S

Manager TitleAgeSince
Carsten Trads CHM
 Chairman 70 31/12/2021
Jeppe Rasmussen BRD
 Director/Board Member 30 19/03/2018
Christian Carlsen BRD
 Director/Board Member 41 28/04/2021
Composition of the Board of Directors

Company details: Dancann Pharma A/S

DanCann Pharma A/S

Rugvænget 5

6823, Ansager

+45 69 16 03 93

http://www.dancann.com
address Dancann Pharma A/S(DANCAN)

Bio Therapeutic Drugs

Add to a list
Add to a list

0 selected

To use this feature you must be a member
Log inSign up
 Change 5d. change 1-year change 3-years change Capi. ($)
DANCANN PHARMA A/S Stock Dancann Pharma A/S
-9.09%-9.09%-89.47%-99.97%425K
VERTEX PHARMACEUTICALS INCORPORATED Stock Vertex Pharmaceuticals Incorporated
-0.94%+2.86%-3.70%+82.32%109B
REGENERON PHARMACEUTICALS, INC. Stock Regeneron Pharmaceuticals, Inc.
-0.25%+0.86%-25.01%+15.00%75.68B
ARGENX SE Stock argenx SE
-0.19%-0.22%+83.67%+149.42%39.89B
BIONTECH SE Stock BioNTech SE
-1.21%-8.28%+13.17%-33.42%27.25B
BEIGENE, LTD. Stock BeiGene, Ltd.
+2.24%+16.22%+18.54%-14.30%21.5B
WUXI APPTEC CO., LTD. Stock WuXi AppTec Co., Ltd.
+0.47%+3.12%-26.32%-53.04%20.77B
NEUROCRINE BIOSCIENCES, INC. Stock Neurocrine Biosciences, Inc.
+0.15%+1.19%+7.51%+91.38%14.43B
SUMMIT THERAPEUTICS INC. Stock Summit Therapeutics Inc.
-1.10%+0.64%+419.22%+698.44%13.42B
GENMAB A/S Stock Genmab A/S
+2.69%-5.01%-25.11%-33.93%13.01B
Average -0.73%-1.99%+37.25%+80.19% 33.52B
Weighted average by Cap. -0.26%-0.22%+19.86%+71.66%
See all sector performances

Sector

Healthcare
Pharmaceuticals & Medical Research
Biotechnology & Medical Research
Biotechnology & Medical Research
Bio Therapeutic Drugs

Annual profits - Rate of surprise

quality-estimates-chart DANCANN-PHARMA-A-S Company calendar

Income Statement and Estimates

income-statement-evolution-chart DANCANN-PHARMA-A-S More financial data
  1. Stock Market
  2. Equities
  3. DANCAN Stock
  4. Company Dancann Pharma A/S
United States

MarketScreener is also available in this country: United States.

Switch edition
Stay in the current country edition